Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Making CAR T-cell therapies more affordable.

Lancet (London, England)·2024
Same author

Medically assisted dying and cancer: a complex issue.

The Lancet. Oncology·2023
Same author

Africa needs to boost HPV vaccine uptake to stem rise in cervical cancer.

The Lancet. Oncology·2023
Same author

NHS embraces AI-assisted radiotherapy technology.

The Lancet. Oncology·2023
Same author

NHS England ends treatment break rule in bowel cancer.

The Lancet. Oncology·2023
Same author

Biomarker tests for targeted oncology therapies pose tricky regulatory challenges.

The Lancet. Oncology·2023

関連する実験動画

Updated: Jul 8, 2026

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

米国の報告書は,予防可能な視力障害に注意を向けています.

Kathryn Senior

    Lancet (London, England)
    |April 12, 2002
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System
    05:10

    An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System

    Published on: March 17, 2023

    Subjective Refraction Test Using a Smartphone for Vision Screening
    05:36

    Subjective Refraction Test Using a Smartphone for Vision Screening

    Published on: October 18, 2024

    関連する実験動画

    Last Updated: Jul 8, 2026

    A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
    09:29

    A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

    Published on: February 11, 2014

    An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System
    05:10

    An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System

    Published on: March 17, 2023

    Subjective Refraction Test Using a Smartphone for Vision Screening
    05:36

    Subjective Refraction Test Using a Smartphone for Vision Screening

    Published on: October 18, 2024